The 2009-2014 Outlook for Artificial Organs in Greater China

Icon Group International, Inc.
December 2, 2008
141 Pages - SKU: ICN2096262
License type:
Countries covered: China

This econometric study covers the latent demand outlook for artificial organs across the regions of Greater China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter referred to as “regions”). Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 1,100 cities in Greater China. For each major city in question, the percent share the city is of the region and of Greater China is reported. Each major city is defined as an area of “economic population”, as opposed to the demographic population within a legal geographic boundary. For many cities, the economic population is much larger that the population within the city limits; this is especially true for the cities of the Western regions. For the coastal regions, cities which are close to other major cities or which represent, by themselves, a high percent of the regional population, actual city-level population is closer to the economic population (e.g. in Beijing). Based on this “economic” definition of population, comparative benchmarks allow the reader to quickly gauge a city’s marketing and distribution value vis-à-vis others. This exercise is quite useful for persons setting up distribution centers or sales force strategies. Using econometric models which project fundamental economic dynamics within each region and city of influence, latent demand estimates are created for artificial organs. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved.

This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the cities in Greater China). This study gives, however, my estimates for the latent demand, or the P.I.E., for artificial organs in Greater China. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Greater China. For each region, I also show my estimates of how the P.I.E. grows over time. In order to make these estimates, a multi-stage methodology was employed that is often taught in courses on international strategic planning at graduate schools of business.


More China Blood Supply, Tissue Banking, Transplantation Reports

Top Ten Companies In Artificial Limb, Man-made Organs & Transplanting Equipment Mfg. Industry In China by Beijing Zeefer Consulting Ltd.
This report provides company profiles and financial data of the top 10 companies in artificial limb, man-made organs & transplanting equipment mfg. industry in China. ...

China Prostheses, Artificial Organs And Implant/Insert Devices Manufacturing Industry, 2012 by Reports From China
China prostheses, artificial organs and implant/insert devices manufacturing industry, 2012 is valuable for anyone who wants to invest in the prostheses, artificial organs and implant/insert ...

China Artificial Limb & Man-Made Organs Mfg. Industry Profile - CIC3686 by Beijing Zeefer Consulting Ltd.
Through a comparative analysis on the development of artificial limb & man-made organs mfg. industry in 31 provincial regions and 20 major cities in visualized ...

Research Report on Global and Chinese Blood Product Industry, 2009 by China Research and Intelligence Co., Ltd.
The blood product industry is stemmed and developed from the blood transfusion, belonging to the conceptual category of biological products. The blood products, extracted the ...

Market Research Report on China Blood Products by SunFAITH China Ltd.
Executive Summary: Blood products refer to human plasma protein fraction. Doctor Zhu Futang from Xiehe Hospital succeeded in Human Placental extractive production in the ...

See all reports like this >>

More China Reports

D&B Country RiskLine Report: China by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

Country Report China February 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

Country Report China January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

D&B Country Report: China by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Wine - BRIC (Brazil, Russia, India, China) Industry Guide by MarketLine
Datamonitor's Wine - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, ...

See all reports like this >>